Find Your Daily Voice
26°
Covid-19: XEC Now Leading Variant in US - Here Are Symptoms
The XEC COVID-19 variant, first identified in Europe, now accounts for 45 percent of cases in the United States, according to the Centers for Disease Control and Prevention (CDC).
Click here for a new, updated story - COVID-19: Virus Levels Now Surging In These States
As infections tick upward, public health experts are urging vigilance.
The strain, a mix of earlier Omicron subvariants, exhibits symptoms similar to Omicron and its predecessors. These include:
Congestion,
Runny nose,
Cough,
Shortness of breath,
Fever or chills,
Fatigue.
Not…
Covid-19: Three More NY Residents Identified As Being Infected With Omicron Variant
Omicron, the new strain of COVID-19 that has caused worldwide alarm the last week, has now been detected in eight New York residents.
On Saturday, Dec. 4, New York Gov. Kathy Hochul announced three more cases have been identified, two days after the state announced its first five cases.
So far, the cases appear unrelated and have been confirmed through sequencing of the SARS-CoV-2 virus, according to the New York State Health Department.
All three of the new cases are from New York City.
Nationally, a total of 23 people have been infected in 11 states: Utah, California, Minneso…
Covid-19: Pill Being Touted As Potential Cure For Virus Could Be Coming
An anti-viral pill that's being touted as a potential cure for COVID-19 could be ready later this year, according to a brand-new report.
PF-07321332, an antiviral drug being developed by Pfizer, is designed to attack the “spine” of the COVID-19 virus to prevent it from replicating in the nose, throat, and lungs, according to the Telegraph.
Trials involving volunteers from age 18 to 60 are now underway at Pfizer facilities in both the United States and Europe, according to the report.
Pizer's director of medicinal chemistry, Dafydd Owen, said the pill was developed from scratch, the Te…
